Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.

Dubois C, Martin F, Hassel C, Magnier F, Daumar P, Aubel C, Guerder S, Mounetou E, Penault-Lorca F, Bamdad M.

J Clin Med. 2019 Dec 26;9(1). pii: E64. doi: 10.3390/jcm9010064.


The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.

Dubois C, Daumar P, Aubel C, Gauthier J, Vidalinc B, Mounetou E, Penault-Llorca F, Bamdad M.

J Clin Med. 2019 Mar 21;8(3). pii: E397. doi: 10.3390/jcm8030397.


Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.

Dubois C, Dufour R, Daumar P, Aubel C, Szczepaniak C, Blavignac C, Mounetou E, Penault-Llorca F, Bamdad M.

Oncotarget. 2017 Aug 24;8(56):95316-95331. doi: 10.18632/oncotarget.20517. eCollection 2017 Nov 10.


Anti-EGFR monoclonal antibodies enhance sensitivity to DNA-damaging agents in BRCA1-mutated and PTEN-wild-type triple-negative breast cancer cells.

El Guerrab A, Bamdad M, Bignon YJ, Penault-Llorca F, Aubel C.

Mol Carcinog. 2017 May;56(5):1383-1394. doi: 10.1002/mc.22596. Epub 2017 Mar 6.


Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer.

El Guerrab A, Bamdad M, Kwiatkowski F, Bignon YJ, Penault-Llorca F, Aubel C.

Oncotarget. 2016 Nov 8;7(45):73618-73637. doi: 10.18632/oncotarget.12037.


BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib.

Dufour R, Daumar P, Mounetou E, Aubel C, Kwiatkowski F, Abrial C, Vatoux C, Penault-Llorca F, Bamdad M.

Sci Rep. 2015 Aug 3;5:12670. doi: 10.1038/srep12670.


BRCA1 induces major energetic metabolism reprogramming in breast cancer cells.

Privat M, Radosevic-Robin N, Aubel C, Cayre A, Penault-Llorca F, Marceau G, Sapin V, Bignon YJ, Morvan D.

PLoS One. 2014 Jul 10;9(7):e102438. doi: 10.1371/journal.pone.0102438. eCollection 2014.


AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.

Privat M, Aubel C, Arnould S, Communal Y, Ferrara M, Bignon YJ.

Anticancer Res. 2010 Jun;30(6):2049-54.


Breast cancer cell response to genistein is conditioned by BRCA1 mutations.

Privat M, Aubel C, Arnould S, Communal Y, Ferrara M, Bignon YJ.

Biochem Biophys Res Commun. 2009 Feb 13;379(3):785-9. doi: 10.1016/j.bbrc.2008.12.151. Epub 2009 Jan 4.


Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.

Amine A, Vozenin-Brotons MC, Abdulkarim B, Violot D, Aubel C, Bourhis J.

Radiat Res. 2006 Oct;166(4):600-10.


Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.

Link N, Aubel C, Kelm JM, Marty RR, Greber D, Djonov V, Bourhis J, Weber W, Fussenegger M.

Nucleic Acids Res. 2006 Jan 30;34(2):e16.


Ornithine decarboxylase activity is inhibited by the polyamine precursor amino acids at the protein stability level in Caco-2 cells.

Chabanon H, Aubel C, Larvaron P, Villard C, Carraro V, Brachet P.

Biochim Biophys Acta. 2005 May 25;1723(1-3):74-81. Epub 2005 Jan 22.


Expression of spermidine/spermine N1-acetyltransferase in HeLa cells is regulated by amino acid sufficiency.

Aubel C, Chabanon H, Carraro V, Wallace HM, Brachet P.

Int J Biochem Cell Biol. 2003 Sep;35(9):1388-98.


Supplemental Content

Loading ...
Support Center